M. Perloff

发表

Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer.

M. Sporn, L. Mariani, G. D'aiuto, 1999, Journal of the National Cancer Institute.

Phase IIa study of fenretinide in superficial bladder cancer, using DNA flow cytometry as an intermediate end point.

M. Costantini, S. Bruno, M. Perloff, 1994, Journal of the National Cancer Institute.